SMTL ID : 4u8z.1

Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06447475)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.63 Å

Oligo State

monomer

Ligands

1 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 2 residues within 4Å: Chain A: N.141, D.154 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.154, H2O.10, H2O.10, H2O.10, H2O.10

1 x 3FE: 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile(Non-covalent)

3FE.2: 14 residues within 4Å: Chain A: I.22, G.23, K.24, V.30, A.43, K.45, E.62, M.91, E.92, Y.93, L.94, L.143, A.153, D.154 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.143, A:A.153, A:D.154 Hydrogen bonds: A:K.24, A:K.45, A:E.92, A:L.94 Water bridges: A:D.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Henderson, J.L. et al., Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. J.Med.Chem. (2015)

Release Date

2015-03-18

Peptides

Serine/threonine-protein kinase 24: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase 24

Related Entries With Identical Sequence